A Director at MiMedx Group is Exercising Options

By Carrie Williams

Today it was reported that a Director at MiMedx Group (MDXGResearch Report), Terry Dewberry, exercised options to buy 50,000 MDXG shares at $0.70 a share, for a total transaction value of $35K.

Following this transaction Terry Dewberry’s holding in the company was increased by 64.83% to a total of $610.2K. Following Terry Dewberry’s last MDXG Buy transaction on October 21, 2009, the stock climbed by 4.0%.

See today’s analyst top recommended stocks >>

Currently, MiMedx Group has an average volume of 384.9K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare.